US Court Overturns Abortion Pill Restrictions

A federal judge in Virginia has ruled that the Food and Drug Administration’s restrictions on the abortion medication mifepristone are unlawful, ordering the Trump administration to reconsider the regulatory framework. The decision challenges long-standing requirements that mandate the drug be dispensed only through certified medical facilities and that patients undergo in-person consultations before receiving the medication. The court found that the FDA failed to provide sufficient scientific or statutory justification for maintaining these limitations.

Mifepristone, approved by the FDA in 2000 for use in early-term pregnancies, has been the subject of ongoing legal and medical debate regarding its distribution protocols. Healthcare providers and patient advocacy groups have consistently argued that the